CABALETTA BIO INC's ticker is CABA and the CUSIP is 12674W109. A total of 54 filers reported holding CABALETTA BIO INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $24,063 | +128.2% | 1,581 | +93.5% | 0.00% | – |
| Q2 2023 | $10,547 | +25011.9% | 817 | -83.7% | 0.00% | -100.0% |
| Q1 2023 | $42 | -6.7% | 5,022 | +2.3% | 0.00% | -50.0% |
| Q4 2022 | $45 | -99.6% | 4,910 | -72.0% | 0.00% | – |
| Q3 2022 | $11,000 | +10.0% | 17,538 | +83.6% | 0.00% | – |
| Q2 2022 | $10,000 | -73.0% | 9,554 | -48.2% | 0.00% | – |
| Q1 2022 | $37,000 | +428.6% | 18,440 | +926.2% | 0.00% | – |
| Q4 2021 | $7,000 | -61.1% | 1,797 | +24.6% | 0.00% | – |
| Q3 2021 | $18,000 | -40.0% | 1,442 | -57.4% | 0.00% | -100.0% |
| Q2 2021 | $30,000 | +66.7% | 3,385 | +113.8% | 0.00% | – |
| Q1 2021 | $18,000 | -58.1% | 1,583 | -54.2% | 0.00% | -100.0% |
| Q4 2020 | $43,000 | -68.6% | 3,455 | -72.7% | 0.00% | -50.0% |
| Q3 2020 | $137,000 | +163.5% | 12,633 | +167.5% | 0.00% | 0.0% |
| Q2 2020 | $52,000 | +136.4% | 4,722 | +59.2% | 0.00% | +100.0% |
| Q1 2020 | $22,000 | -37.1% | 2,967 | +16.9% | 0.00% | -66.7% |
| Q4 2019 | $35,000 | – | 2,538 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 2,106,000 | $32,053,320 | 21.20% |
| COMMODORE CAPITAL LP | 2,525,753 | $38,441,961 | 4.49% |
| Bain Capital Life Sciences Investors, LLC | 2,000,000 | $30,440,000 | 3.40% |
| VR Adviser, LLC | 1,973,253 | $30,032,911 | 3.16% |
| Cormorant Asset Management, LP | 2,879,424 | $43,824,833 | 2.56% |
| Velan Capital Investment Management LP | 150,000 | $2,283,000 | 1.84% |
| Redmile Group, LLC | 1,774,252 | $27,004,115 | 1.28% |
| TCG Crossover Management, LLC | 486,795 | $7,409,020 | 1.09% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,340,118 | $35,616,596 | 0.78% |
| Integral Health Asset Management, LLC | 330,000 | $5,022,600 | 0.70% |